Development and validation of a selective and sensitive LC-MS/MS method for determination of cycloserine in human plasma: Application to bioequivalence study

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 879, Issue 23, 2011, Pages 2265-2273

  Patel, Dinesh S ^a,b   Sharma, Naveen ^b   Patel, Mukesh C ^a   Patel, Bhavin N ^b,c   Shrivastav, Pranav S ^c   Sanyal, Mallika ^d  

^a PS Science and HDPatel Arts College   (India)

^b BA Research India Limited   (India)

^c GUJARAT UNIVERSITY   (India)

^d ST XAVIER S COLLEGE   (India)

Author keywords

Bioequivalence; Cycloserine; Human plasma; LC MS MS; Solid phase extraction

Indexed keywords

BIOEQUIVALENCE; CYCLOSERINE; HUMAN PLASMAS; LC-MS/MS; SOLID PHASE EXTRACTION;

CARBOXYLIC ACIDS; CHROMATOGRAPHY; EXTRACTION; HIGH PRESSURE LIQUID CHROMATOGRAPHY; IONS; MASS SPECTROMETRY; PLASMAS; PYRIDINE; STANDARDIZATION;

PLASMA (HUMAN);

CYCLOSERINE; NICOTINIC ACID;

ACCURACY; ADULT; ARTICLE; BIOEQUIVALENCE; DILUTION; DRUG BIOAVAILABILITY; DRUG DETERMINATION; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

CHROMATOGRAPHY, LIQUID; CYCLOSERINE; HUMANS; MALE; TANDEM MASS SPECTROMETRY; THERAPEUTIC EQUIVALENCY;

EID: 79960557826     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2011.06.011     Document Type: Article

References (21)

1. Lowy F.D. J. Clin. Invest. 2003, 111:1265.
2. Greenwood D., Whitley R. Antibiotic and Chemotherapy 2002, 11. Churchill Livingstone, New York. 8th ed. R.G. Finch, D. Greenwood, S.R. Norrby, R. Whitley (Eds.).
3. David S. J. Antimicrob. Chemother. 2001, 47:203.
4. Neuhhaus F.C. Antibiotics. I. Mechanism of Action 1967, 40. Springer-Verlag, Berlin, Heidelberg, New York. D. Gottlieb, P.D. Shaw (Eds.).
5. Abbanat D., Macielag M., Bush K. Expert Opin. Investig. Drugs 2003, 12:379.
6. Scotto P., Monaco P., Scardi V., Bonavita V. J. Neurochem. 1964, 10:831.
7. El-Sayed L., Mohamed Z.H., Wahli A.A.M. Analyst (Lond.) 1986, 111:915.
8. Steward J.T., Yoo G.S. J. Pharm. Sci. 1988, 77:452.
9. Wahbi A.M., Mohamed M.E., Abounassif M., Gad-Kariem E. Anal. Lett. 1985, 18:261.
10. Jayaram B., Gowda N.M.N. Anal. Chim. Acta 1985, 173:381.
11. Yoo G.S., Choi K., Stewart J.T. Anal. Lett. 1990, 23:1245.
12. Pendela M., Dragovic S., Bockx L., Hoogmartens J., Schepdael A.V., Adams E. J. Pharm. Biomed. Anal. 2008, 47:807.
13. Tanaka Y., Otsuka K., Terabe S. J. Chromatogr. A 2000, 875:323.
14. Karthikeyan K., Arularasu G.T., Ramadhas R., Pillai K.C. J. Pharm. Biomed. Anal. 2011, 54:850.
15. Yew W.W., Cheung S.W., Chau C.H., Chan C.Y., Leung C.K., Cheng A.F.B., Wong C.F. Int. J. Clin. Pharmacol. Res. 1999, 19:65.
16. Musson D.G., Maglietto S.M., Hwang S.S., Gravellese D., Bayne W.F. J. Chromatogr. 1987, 414:121.
17. David V., Ionescu M., Dumitrescu V. J. Chromatogr. B 2001, 761:27.
18. Guidance for Industry, Bionanlytical Method Validation, US Department of Health and Human Services, Food and Drug Administration Centre for Drug Evaluation and Research (CDER), Centre for Veterinary Medicine (CVM), May 2001.
19. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Anal. Chem. 2003, 75:3019.
20. Guidance for Industry: ICH E6 Good Clinical Practice, U.S. Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER), Centre for Biologics Evaluation and Research (CBER), April 1996.
21. Rocci M.L., Devanarayan V., Haughey D.B., Jardieu P. AAPS J. 2007, 9:E336.